1INN.XETRA innoscripta SE
- Market cap
- EUR 448M
- P/E
- 8.5x
- P/B
- 11.67x
- ROE
- 128.5%
- Dividend yield
- 5.36%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 1INN.XETRA undervalued?
Graham number1INN.XETRA trades 109.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
innoscripta SE fundamental analysis
No fundamental analysis for innoscripta SE yet.
innoscripta SE stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About innoscripta SE
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in European markets, including Germany, France, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia, the Netherlands, and the United Kingdom. It offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage i…
Full company profileinnoscripta SE financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
innoscripta SE annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 27.3M | 39.4M | 64.7M | 103M | 126M |
| Gross Profit | 15.7M | 23.5M | 48.0M | 77.0M | 92.9M |
| Operating Income | 9.15M | 15.6M | 37.3M | 63.5M | 71.9M |
| EBITDA | 9.46M | 15.7M | 37.7M | 63.8M | 73.1M |
| Net Income | 6.10M | 10.3M | 25.1M | 42.6M | 49.3M |
| EPS | 0.61 | 1.03 | 2.51 | 4.26 | 4.93 |
| Balance Sheet | |||||
| Total Assets | 30.0M | 35.4M | 58.8M | 101M | 83.5M |
| Total Liabilities | 17.3M | 17.3M | 23.7M | 47.2M | 45.2M |
| Shareholders' Equity | 12.7M | 18.1M | 35.1M | 53.8M | 38.4M |
| Cash & Short-term Investments | 12.6M | 13.7M | 23.9M | 46.7M | 30.0M |
| Cash Flow | |||||
| Operating Cash Flow | 8.89M | 5.26M | 20.1M | 40.8M | 50.0M |
| Capital Expenditure | 326K | 259K | 142K | 191K | 2.01M |
| Free Cash Flow | 8.56M | 5.00M | 20.0M | 40.6M | 47.9M |
| Ratios | |||||
| ROE | 48.0% | 56.9% | 71.4% | 79.2% | 128.5% |
| ROA | 20.3% | 29.0% | 42.7% | 42.2% | 59.0% |
| Net Profit Margin | 22.4% | 26.1% | 38.8% | 41.2% | 39.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
innoscripta SE dividends
- Dividend yield
- 5.36%
- Forward dividend
- 4.00 EUR
- Payout ratio
- 56.3%
- Ex-dividend date
- Apr 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 24.0M | 2.40 | 56.3% |
| 2024 | EUR 8.00M | 0.80 | 31.9% |
| 2023 | EUR 5.00M | 0.50 | 48.7% |
| 2022 | EUR 4.00M | 0.40 | 65.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns innoscripta SE
- Insiders 84.70%
- Institutions 6.19%
- Public & others 9.11%
- Shares outstanding 10.0M
- Free float 1.69M
innoscripta SE company profile
- Company name
- innoscripta SE
- Ticker
- 1INN.XETRA
- ISIN
- DE000A40QVM8
- Exchange
- XETRA Stock Exchange
- Sector
- Technology
- Industry
- Software - Application
- Employees
- 396
- Fiscal year end
- December
- Address
- Arnulfstraße 60, Munich, Germany, 80335
- Phone
- 49 (89) 25555 3537
- Website
- innoscripta.com
About innoscripta SE
innoscripta SE provides software-as-a-service for managing research and development (R&D) tax incentives and project management consulting in European markets, including Germany, France, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia, the Netherlands, and the United Kingdom. It offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable. It offers solutions for research and development documentation, such as human resources, task management, organization, project management, and time tracking. It serves the additive manufacturing/3D printing; aerospace engineering; automotive; biotechnology; business consulting and technical services; chemical; construction; electrical engineering; energy; environmental technology and circular economy financial services/fintech; food and beverage; IT and software development; metal working; medical technology; mechanical engineering; manufacturing for industry; logistics; optical engineering and photonics; pharmaceutical; retail; research and development; textile industry/technical textiles; and professional, scientific, and technical services industries. The company was incorporated in 2012 and is headquartered in Munich, Germany. innoscripta SE operates as a subsidiary of Hohenester Beteiligungs-Ug (Haftungsbeschränkt).
innoscripta SE management
4- Mr. Michael Georg HohenesterFounder, CO-CEO & Chairman of the Management Board · born 1983
- Mr. Alexander MeyerCo-CEO, CFO & Member of the Management Board · born 1986
- Mr. Sebastian SchwertleinCOO & Member of the Management Board · born 1992
- Max HungerHead of Investor Relations